EUVIMEDEUVIMED entdecken
Crossref

High depth targeted next-generation sequencing in vascular malformations

Pattima Pakhathirathien iD, Parith Wongkittichote, Sanchawan Wittayakornrerk, Tharintorn Treesit, Sasikorn Feinggumloon, Kaewpitcha Pichipichatkul, Chinnarat Bua-Ngam, Ajchariya Sarovath, Pornsri Thanachatchairattana, Sarayuth Dumrongwongsiri, Kevin M Bowling, Meagan M Corliss und 5 weitere

Human Molecular Genetics · 2026

DOI: 10.1093/hmg/ddaf169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Pattima Pakhathirathien und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok 1…. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Vascular Malformations. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Faculty of Medicine Ramathibodi Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A vascular anomaly could be a vascular tumor or a vascular malformation. Vascular malformation is subclassified into fast-flow, including arteriovenous malformation and portwine stain, and slow-flow group comprising venous malformation, lymphatic malformation, and venolymphatic malformation. Recent data have shown that somatic mutations of genes in PIK3/AKT/mTOR and RAS/MAPK/ERK pathways are a major cause of this disorder. We conducted a gene panel testing (129 genes) with high-depth next-generation sequencing (NGS), which can detect very low-level mosaicism (~ 1%), on the tissue obtained from 26 patients in a cohort of mixed types of vascular malformation, comprising 2 fast-flow and 24 slow-flow malformations. Pathogenic/likely pathogenic (P/LP) variants were identified in 21 of 26 patients, yielding the overall diagnostic rate of 80.8%. The leading causes identified were PIK3CA (57.1%) and TEK (33.3%), especially in the slow-flow group, whereas HRAS and GNAQ were found positive in patients with fast-flow malformations. Three of 11 P/LP variants were previously unreported in vascular malformation, including those from HRAS, PIK3CA, and TEK. Most variants were detected as a solo, except for double mutations of TEK in patients with blue rubber bleb nevus syndrome (BRBNS) and a non-syndromic venous malformation. The level of mosaicism in the tissue ranged from 0.93% to 16.53%, with 60% (15/25) of the variants having ≥ 5% mosaicism. Three variant of uncertain significance of IDH1 and NACC1 were found and deserve further investigation for their pathogenic role. Data from the present study suggest the potential benefit of targeted therapy, in particular drugs in the mTOR pathway, for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingVascular MalformationsHumansFemaleMaleMutationAdultClass I Phosphatidylinositol 3-KinasesChildChild, PreschoolAdolescentMiddle AgedMosaicismInfantYoung AdultProto-Oncogene Proteins p21(ras)

Stichwörter der Autor:innen

PIK3CATEKarteriovenous malformationvenous malformation

Substanzen

PIK3CA protein, humanClass I Phosphatidylinositol 3-KinasesProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Division of Genetics, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok 10400, Thailand.
  • Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, 15 Kanchanavanich Road, Hatyai, Songkhla, 90100, Thailand.
  • Division of Ambulatory and Adolescent Medicine, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok 10400, Thailand.
  • Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok, 10400, Thailand.
  • Department of Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok 10400, Thailand.
  • Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, United States.

ORCID-Profile: Pattima Pakhathirathien

Förderung

  • Faculty of Medicine Ramathibodi Hospital

Zitieren

APA

Pakhathirathien, P., Wongkittichote, P., Wittayakornrerk, S., Treesit, T., Feinggumloon, S., Pichipichatkul, K., Bua-Ngam, C., Sarovath, A., Thanachatchairattana, P., Dumrongwongsiri, S., Bowling, K. M., Corliss, M. M., Cao, Y., Tim-Aroon, T., Khongkraparn, A., Noojaroen, S., & Wattanasirichaigoon, D. (2026). High depth targeted next-generation sequencing in vascular malformations. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf169

Vancouver

Pakhathirathien P, Wongkittichote P, Wittayakornrerk S, Treesit T, Feinggumloon S, Pichipichatkul K, et al. High depth targeted next-generation sequencing in vascular malformations. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddaf169

BibTeX
@article{Pakhathirathien2026,
  author = {Pakhathirathien, Pattima and Wongkittichote, Parith and Wittayakornrerk, Sanchawan and Treesit, Tharintorn and Feinggumloon, Sasikorn and Pichipichatkul, Kaewpitcha and Bua-Ngam, Chinnarat and Sarovath, Ajchariya and Thanachatchairattana, Pornsri and Dumrongwongsiri, Sarayuth and Bowling, Kevin M and Corliss, Meagan M and Cao, Yang and Tim-Aroon, Thipwimol and Khongkraparn, Arthaporn and Noojaroen, Saisuda and Wattanasirichaigoon, Duangrurdee},
  title = {High depth targeted next-generation sequencing in vascular malformations},
  journal = {Human Molecular Genetics},
  year = {2026},
  doi = {10.1093/hmg/ddaf169}
}
Kostenlos starten →